iHub My Stocks Activity
Ticker Buzz Cloud
Most Followed Members
Data Tools >
Markets in 3D
More Tools >
My Image Gallery
Personal Finance Q&A
Immune Network Ltd (fka IMMFF)
Add Price Alert
Search This Board:
1/17/2013 9:42:28 AM
- Board type:
- Posts Today:
IMMFF -- Immune Network Ltd.
2906 West Broadway
Vancouver, BC V6K 2G8
Immune Network Ltd. is a biotechnology company focused on the development of new drugs to treat major diseases predominantly involving the body's immune system. The Company's projects include Alzheimer Project AD2 and AIDS Project 1F7 and hNM01, including Hepatitis C Monoclonal Antibodies. During the year ended December 31, 2001, Immune Network suspended various projects due, in part, to fiscal constraints and for commercial reasons, although it has retained an interest in some of the projects by way of royalties in future revenues, if any. Suspended projects include Asthma Project BP1, Eczema Project BP1249, Cancer Project Viraplex, and Herpes Cold Sore Project Zorex.
Primary State of Incorporation: British Columbia
Country of Incorporation: CANADA
Allen Bain, President/CEO; Mark Glusing, COO/CFO/Secretary
Outstanding Shares: 19,810,890 as of 2002-07-17
Current Capital Change:
shs decreased by 1 for 10 split
Pay Date: 2002-07-29
Formerly=Immune Network Research Ltd. until 8-00
Computershare Trust Company of Canada Inc., Vancouver, BC V6C 3B9
Immune Network's Phase 2 clinical trial results in Alzheimer’s disease. Preliminary evidence suggests that certain nano-pharmaceutical formulations may improve the potency and safety of dapsone for Alzheimer’s disease, an existing drug which is FDA-approved for other indications.
Immune Network to Tackle Diabetes
Market Wire, January, 2006
Immune Network Ltd. (OTC: IMMFF) advises that it has acquired an 85% interest in B.C.-based Dr Nature Health Products Inc. -- which has a breakthrough natural health product, DRN 11, that is proven clinically beneficial in the management of diabetes -- in exchange for 7.5 million Immune Network shares.
Immune will now commence marketing DRN 11, the flagship product developed by Dr Nature over the past eight years. Completed regulatory filing for DRN 11 in Canada allows the Company to commence sales immediately. Sales into the U.S. and other markets will also be pursued.
Pre-clinical studies have demonstrated that DRN 11 sensitizes the body's response to its own insulin making it work more efficiently (by increasing insulin binding and internalization). As a result of better utilization of insulin, muscle cell glucose uptake is increased. The significant clinical benefits against all diabetes symptoms and complications have been demonstrated through three DRN 11 clinical studies.
DRN 11 is an excellent supplement compound that can be used alongside prescription medications such as the US$800 million drug Metformin. In the DRN 11 clinical studies, reductions in the range of 15-20% in blood sugar levels have complemented a noted quality of life benefit with no side effects and an overall improvement in the well being and general health of the study participants.
Diabetes is the third leading cause of death in the United States with an economic cost of over $100 billion per year and affecting 18.2 million people with an estimated 15 million not yet diagnosed.
Safe Harbor Statement
The information in this release, other than historical information, may be considered forward-looking statements within the provisions of the Private Securities Litigation Reform Act of 1995. Projection and other forward-looking statements and management expectations regarding future events and/or financial performance of the Company -- although given in good faith -- are inherently uncertain and actual events and/or results may differ materially.
For further information contact: Dr. Allen Bain 1-650-241-1888 Email Contact
Post New Msg
My Stocks (0)
01/17/13 09:42:28 AM
IMMFF: SEC Suspension:
12/20/12 09:38:10 AM
Does any one knows how many millions o/s
07/08/11 09:01:47 AM
Immunitor Publishes Interim Data From Phase IIb imm01
12/30/10 09:23:46 AM
100 billion annual world market!
11/29/10 09:29:54 AM
wheres the news!
11/29/10 09:29:09 AM
,,,,,,I think today's news good for a few pence--MONEYMADE
11/29/10 09:27:08 AM
first they have to make the SEC filing,
09/23/10 02:20:47 AM
Thanks lifegear! Nothing seems to move this
02/13/07 10:04:20 PM
NEWS TODAY: Immune Network to Farm in on
02/13/07 06:20:24 PM
19M or less ... only problem is no
09/10/06 01:21:18 PM
I think the float is really tiny
09/10/06 12:53:54 PM
Either they don't want to spend the money
09/10/06 12:44:37 PM
but the acquisition was just Jan 2006...they don't
09/10/06 12:41:17 PM
Virtually no trading volume to speak of ...
09/10/06 08:03:03 AM
Website news goes back to 2003 .. hope
09/10/06 07:59:57 AM
Immune Network Ltd. is a biotechnology company focused
09/09/06 09:54:56 PM
I found it...85% acquisition
09/09/06 09:51:26 PM
maybe it's time to add some more....I thought
09/09/06 09:47:51 PM
sure hope so .. maybe a little ACTC
09/09/06 09:29:24 PM
me too...it's about time something happens to this
09/09/06 08:56:11 PM
I have owned some of this for years
09/09/06 05:37:50 PM
Post New Msg
My Stocks (0)
© 2016 InvestorsHub.Com, Inc.
Terms of Service
Advertise With Us
Stock Market 101
Investor Help Forum
Personal Finance Q&A
iHub on Facebook
iHub on Twitter
iHub iPhone/iPad App
iHub Android App
iHub BlackBerry App